booster demand in cities like chicago for that initial 65% of adults that need to get vaccinated. the white house did say yesterday that once that approval does occur, they re working with their partners to make sure that all types of the boosters will be readily available, geoff. nbc s maura barrett, thanks so much. a highly anticipated new study on mixing and matching covid vaccinations shows it s both safe and effective. mixing and matching means giving a booster dose of a vaccine different from the initial vaccine dose. for example, if you get the johnson & johnson shot the first time around but then the pfizer booster. so the nih study found it s both safe and effective. the findings will be presented friday to the fda s advisory panel. joining us now is the national co-principal investigator of that study, dr. robert atmar, professor of infectious diseases at baylor college of medicine in texas. good to have you with us. the study found that mixing these vaccines is safe.
and the cdc predicts hospitalizations and deaths will continue to fall over the coming months. and tomorrow and friday, the fda s vaccine advisers are going to meet to talk boosters of moderna and johnson & johnson. moderna basically wants to roll out essentially a half dose as a booster. and meantime, an nih study says it is safe and effective to mix and match your first doses and your booster do not need to be the same brand. wolf. very interesting indeed. nick watt reporting for us, thank you very much. let s dig deeper right now. joining us, our chief medical correspondent, dr. sanjay gupta, also the author of a brand-new book, you see the cover world war c, lessons from the covid-19 pandemic and how to prepare for the next one. thank you as usual for joining us. more than 104,000 people here in the united states died of covid-19 between june and
demanded the intelligence community redouble its efforts in investigating the virus origins and in a joint statement with the eu called for a new probe free from interference. hhs watchdog has launched a probe into how the nih gives out grants as it reveals a nonprofit that receives one gave its money to the wuhan lab. it all comes as an nih study reveals covid 19 may have been present in the us as early as 2019. researchers say 7 people in 5 states tested positive for covid andy bodies in early 2020 weeks before health official started recognizing cases. the first us coronavirus case was confirmed in late january 2020, that patient tested positive in washington state after traveling to wuhan. the cdc did not identify infections that were unrelated to travel in china more than a month later in february. todd: i think my wife had it when we were on vacation in
they allowed china, the group of scientists to investigate. that s not consistent with their little. reporter: two house republicans introducing a bill that would sanction chinese officials until they allow for a new probe. there needs to be an open, transparent and independent evaluation of what happened at the wuhan institute of virology, the chinese have not been willing to do that and the only way to make that happen is to be aggressive, to be directing what we expect out of china. president biden demanded the intelligence community redouble its efforts investigate the virus origins into the joint summit statement with the eu calls for a new probe free from interference. hhs watchdog launched a probe into how the nih gives out grants after it was revealed that a nonprofit that received one gave its money to the wuhan lab. it comes as an nih study reveals covid 19 may have been present
Researchers to study mixing and matching different COVID-19 vaccines as boosters
Researchers are testing new forms of booster vaccines.
and last updated 2021-06-03 18:16:32-04
As the country pushes to get more people vaccinated, researchers are now looking at mixing and matching different COVID vaccines as a booster for fully vaccinated people.
âWe call it mix and match because weâre looking at people who got any of the three EUA authorized vaccines: the Pfizer, the Moderna, or the Janssen vaccine,â said Dr. Robert Atmar, one of the trialâs principal investigators. âAt least in the current part of the study, weâre boosting each of those three groups with the Moderna vaccine.â